AGGRESSIVE CHOLESTEROL THERAPY TO INHIBIT VEIN GRAFT EVENTS (ACTIVE TRIAL): DOES HIGH-DOSE POSTOPERATIVE STATIN THERAPY IMPROVE GRAFT PATENCY AFTER CORONARY BYPASS.
- Registry ID
- 20120222-01
- Source registry
- HEALTH_CANADA
- Status
- Pending
- Study type
- INTERVENTIONAL
- Sponsor
- OTTAWA HEART INSTITUTE RESEARCH CORPORATION
- Last update
- 2013-05-14
Conditions
- CORONARY ARTERY BYPASS GRAFT
- CORONARY HEART DISEASE OR HIGH RISK OF CORONONARY HEART DISEASE
Related clinical trials
- A RANDOMIZED, PLACEBO-CONTROLLED, PARALLEL-GROUP, INVESTIGATOR- AND PARTICIPANT-BLINDED PHASE 2A STUDY TO INVESTIGATE THE EFFICACY, SAFETY, AND TOLERABILITY OF DFV890 FOR INFLAMMATORY MARKER REDUCTION IN ADULT PARTICIPANTS WITH CORONARY HEART DISEASE AND ELEVATED HSCRP
- A PROSPECTIVE, COMPARATIVE, RANDOMIZED, MULTI-CENTER, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2A STUDY OF THE SAFETY AND EFFICACY OF CMX-2043 FOR PERIPROCEDURAL INJURY PROTECTION IN SUBJECTS UNDERGOING CORONARY ANGIOGRAPHY AT RISK OF RADIO-CONTRAST INDUCED NEPHROPATHY (CARIN)
- ELIMINATE CORONARY HEART DISEASE
View on source registry